PA8813901A1 - Paramixovirus oncolíticos atenuados que codifican citoquinas de aves - Google Patents
Paramixovirus oncolíticos atenuados que codifican citoquinas de avesInfo
- Publication number
- PA8813901A1 PA8813901A1 PA20098813901A PA8813901A PA8813901A1 PA 8813901 A1 PA8813901 A1 PA 8813901A1 PA 20098813901 A PA20098813901 A PA 20098813901A PA 8813901 A PA8813901 A PA 8813901A PA 8813901 A1 PA8813901 A1 PA 8813901A1
- Authority
- PA
- Panama
- Prior art keywords
- virus
- oncolitical
- bird
- codify
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18141—Use of virus, viral particle or viral elements as a vector
- C12N2760/18143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18161—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
UN VIRUS A ARN ONCOLÍTICO RECOMBINANTE DE LA ENFERMEDAD DE NEWCASTLE PARA EL TRATAMIENTO DE UNA ENFERMEDAD PROLIFERATIVA, QUE COMPRENDE AL MENOS UN TRANSGEN QUE CODIFICA UNA CITOQUINA DE AVES, EN DONDE EL VIRUS A ARN ONCOLÍTICO RECOMBINANTE DE LA ENFERMEDAD DE NEWCASTLE SE PUEDE OBTENER A PARTIR DE UN VIRUS A ARN DE LA ENFERMEDAD DE NEWCASTLE ONCOLÍTICO VELOGÉNICO O MESOGÉNICO. LA EXPRESIÓN MEDIADA POR VIRUS DE LA CITOQUINA EN LAS CÉLULAS HUÉSPED NATURAL CONDUCE A UNA PATOGENICIDAD REDUCIDA DEL VIRUS PARA ESPECIES DE AVES. AÚN MÁS, EL GENOMA DEL VIRUS PUEDE CODIFICAR PROTEÍNAS DE UNIÓN, ENZIMAS CONVERTIDORAS DE PRODROGAS O/Y PROTEASAS. LA EXPRESIÓN SELECTIVA DE ESTAS MOLÉCULAS EN CÉLULA TUMORALES INFECTADAS CON VIRUS INCREMENTA EL EFECTO ANTIMURAL DEL VIRUS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2433308P | 2008-01-29 | 2008-01-29 | |
EP08001643A EP2085092A1 (en) | 2008-01-29 | 2008-01-29 | Attenuated oncolytic paramyxoviruses encoding avian cytokines |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8813901A1 true PA8813901A1 (es) | 2009-08-26 |
Family
ID=39708421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20098813901A PA8813901A1 (es) | 2008-01-29 | 2009-01-28 | Paramixovirus oncolíticos atenuados que codifican citoquinas de aves |
Country Status (22)
Country | Link |
---|---|
US (1) | US20100092430A1 (es) |
EP (2) | EP2085092A1 (es) |
JP (1) | JP2011510638A (es) |
KR (1) | KR20100113096A (es) |
CN (1) | CN102099045A (es) |
AR (1) | AR070272A1 (es) |
AU (1) | AU2009210301A1 (es) |
BR (1) | BRPI0906354A2 (es) |
CA (1) | CA2711571A1 (es) |
CL (1) | CL2009000190A1 (es) |
CO (1) | CO6290693A2 (es) |
CR (1) | CR11616A (es) |
DO (1) | DOP2010000233A (es) |
EA (1) | EA201001202A1 (es) |
EC (1) | ECSP10010375A (es) |
IL (1) | IL206382A0 (es) |
MX (1) | MX2010008370A (es) |
PA (1) | PA8813901A1 (es) |
PE (1) | PE20091355A1 (es) |
TW (1) | TW200936159A (es) |
WO (1) | WO2009095167A1 (es) |
ZA (1) | ZA201006151B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2251034T (pt) | 2005-12-02 | 2018-05-22 | Icahn School Med Mount Sinai | Vírus da doença de newcastle quiméricos que apresentam proteínas de superfície não nativas e suas utilizações |
WO2010091262A1 (en) | 2009-02-05 | 2010-08-12 | Mount Sinai School Of Medicine Of New York University | Chimeric newcastle disease viruses and uses thereof |
US9937196B2 (en) * | 2009-06-19 | 2018-04-10 | University Of Maryland, College Park | Genomic sequence of avian paramyxovirus type 2 and uses thereof |
PL2739293T3 (pl) * | 2011-08-05 | 2020-11-16 | Sillajen Biotherapeutics, Inc. | Sposoby i kompozycje wytwarzania wirusa krowianki |
BR112015021414B1 (pt) * | 2013-03-14 | 2020-11-10 | Icahn School Of Medicine At Mount Sinai | vírus da doença newcastle e seus usos |
KR102310692B1 (ko) * | 2013-09-03 | 2021-10-12 | 메디뮨 리미티드 | 약독화된 뉴캐슬병 바이러스를 특징으로 하는 조성물 및 신생물을 치료하기 위한 사용 방법 |
WO2015127501A1 (en) | 2014-02-27 | 2015-09-03 | Viralytics Limited | Combination method for treatment of cancer |
GB201505860D0 (en) * | 2015-04-07 | 2015-05-20 | Agalimmune Ltd | Therapeutic compositions and methods of use for treating cancer |
CN108362875A (zh) * | 2018-01-10 | 2018-08-03 | 华南农业大学 | 一种鉴别新城疫感染与免疫的间接elisa方法 |
CN111094324B (zh) * | 2018-03-14 | 2023-10-10 | 武汉博威德生物技术有限公司 | 一种溶瘤病毒、合成dna序列及其应用 |
TW202043466A (zh) * | 2019-01-25 | 2020-12-01 | 德商百靈佳殷格翰國際股份有限公司 | 編碼ccl21之重組棒狀病毒 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE257175T1 (de) | 1994-07-18 | 2004-01-15 | Conzelmann Karl Klaus Prof Dr | Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus |
US20030044384A1 (en) | 1997-10-09 | 2003-03-06 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
EP0974660A1 (en) | 1998-06-19 | 2000-01-26 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
EP1390046A4 (en) | 1999-04-15 | 2005-04-20 | Wellstat Biologics Corp | TREATMENT OF NEOPLASMS WITH VIRUSES |
WO2000067786A1 (en) | 1999-05-05 | 2000-11-16 | University Of Maryland | PRODUCTION OF NOVEL NEWCASTLE DISEASE VIRUS STRAINS FROM cDNAS AND IMPROVED LIVE ATTENUATED NEWCASTLE DISEASE VACCINES |
US20030224017A1 (en) | 2002-03-06 | 2003-12-04 | Samal Siba K. | Recombinant Newcastle disease viruses useful as vaccines or vaccine vectors |
DE19932688B4 (de) | 1999-07-13 | 2009-10-08 | Scil Proteins Gmbh | Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen |
CA2312626A1 (en) | 1999-07-27 | 2001-01-27 | Akzo Nobel N.V. | A recombinant newcastle disease virus as an embryo vaccine |
US8147822B1 (en) | 1999-09-17 | 2012-04-03 | Wellstat Biologics Corporation | Oncolytic virus |
WO2001020989A1 (en) | 1999-09-22 | 2001-03-29 | Mayo Foundation For Medical Education And Research | Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
AU2002224815B2 (en) | 2000-11-02 | 2006-10-12 | Intervet International B.V. | A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
JP2004537305A (ja) | 2001-07-11 | 2004-12-16 | ユニバーシティー オブ マイアミ | 腫瘍細胞の処置のための組換えvsv |
EP1300157B1 (en) | 2001-10-04 | 2005-10-26 | Centrum voor Onderzoek in Diergeneeskunde en Agrochemie | Attenuated mutant newcastle disease virus strains for in ovo vaccination and their use |
US20040072276A1 (en) | 2002-05-10 | 2004-04-15 | Direvo BioTech AG. | Process for generating sequence-specific proteases by directed evolution and use thereof |
JP2006527738A (ja) | 2003-06-18 | 2006-12-07 | ディレボ・ビオテク・アーゲー | 新規生物学的実体およびその薬学的または診断的使用 |
CN101056646A (zh) | 2004-11-12 | 2007-10-17 | 拜耳先灵医药股份有限公司 | 重组新城疫病毒 |
CN1772886A (zh) | 2005-09-02 | 2006-05-17 | 中国农业科学院哈尔滨兽医研究所 | 表达传染性法氏囊病毒VP2基因的重组新城疫LaSota弱毒疫苗株 |
-
2008
- 2008-01-29 EP EP08001643A patent/EP2085092A1/en not_active Withdrawn
-
2009
- 2009-01-20 JP JP2010544616A patent/JP2011510638A/ja not_active Withdrawn
- 2009-01-20 CN CN2009801035310A patent/CN102099045A/zh active Pending
- 2009-01-20 EA EA201001202A patent/EA201001202A1/ru unknown
- 2009-01-20 CA CA2711571A patent/CA2711571A1/en not_active Abandoned
- 2009-01-20 BR BRPI0906354A patent/BRPI0906354A2/pt not_active Application Discontinuation
- 2009-01-20 WO PCT/EP2009/000308 patent/WO2009095167A1/en active Application Filing
- 2009-01-20 MX MX2010008370A patent/MX2010008370A/es not_active Application Discontinuation
- 2009-01-20 AU AU2009210301A patent/AU2009210301A1/en not_active Abandoned
- 2009-01-20 EP EP09704993A patent/EP2237790A1/en not_active Withdrawn
- 2009-01-20 KR KR1020107016944A patent/KR20100113096A/ko not_active Application Discontinuation
- 2009-01-23 TW TW098103098A patent/TW200936159A/zh unknown
- 2009-01-28 US US12/361,201 patent/US20100092430A1/en not_active Abandoned
- 2009-01-28 AR ARP090100255A patent/AR070272A1/es unknown
- 2009-01-28 PA PA20098813901A patent/PA8813901A1/es unknown
- 2009-01-29 CL CL2009000190A patent/CL2009000190A1/es unknown
- 2009-01-29 PE PE2009000128A patent/PE20091355A1/es not_active Application Discontinuation
-
2010
- 2010-06-15 IL IL206382A patent/IL206382A0/en unknown
- 2010-07-29 CR CR11616A patent/CR11616A/es not_active Application Discontinuation
- 2010-07-29 CO CO10092654A patent/CO6290693A2/es not_active Application Discontinuation
- 2010-07-29 EC EC2010010375A patent/ECSP10010375A/es unknown
- 2010-07-29 DO DO2010000233A patent/DOP2010000233A/es unknown
- 2010-08-27 ZA ZA2010/06151A patent/ZA201006151B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP10010375A (es) | 2010-08-31 |
BRPI0906354A2 (pt) | 2019-12-17 |
DOP2010000233A (es) | 2010-08-15 |
CN102099045A (zh) | 2011-06-15 |
CO6290693A2 (es) | 2011-06-20 |
US20100092430A1 (en) | 2010-04-15 |
KR20100113096A (ko) | 2010-10-20 |
CR11616A (es) | 2010-09-09 |
EP2085092A1 (en) | 2009-08-05 |
JP2011510638A (ja) | 2011-04-07 |
MX2010008370A (es) | 2010-08-23 |
CA2711571A1 (en) | 2009-08-06 |
TW200936159A (en) | 2009-09-01 |
AR070272A1 (es) | 2010-03-25 |
PE20091355A1 (es) | 2009-10-04 |
AU2009210301A1 (en) | 2009-08-06 |
WO2009095167A1 (en) | 2009-08-06 |
IL206382A0 (en) | 2010-12-30 |
ZA201006151B (en) | 2012-02-29 |
EA201001202A1 (ru) | 2011-02-28 |
CL2009000190A1 (es) | 2010-07-19 |
EP2237790A1 (en) | 2010-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8813901A1 (es) | Paramixovirus oncolíticos atenuados que codifican citoquinas de aves | |
AR116107A2 (es) | Método para la producción de promotores constitutivos de plantas, constructos y células transgénicas | |
ES2568803T3 (es) | Reducción del contenido de ácidos grasos saturados en semillas de plantas | |
AR090470A1 (es) | Vacuna contra el virus sincicial respiratorio (rsv) | |
MX2013003681A (es) | Ácidos nucleicos manipulados y métodos de uso de los mismos. | |
AR059257A1 (es) | Genes para mejorar la eficiencia de la utilizacion de nitrogeno en los cultivos | |
EA201171018A1 (ru) | Биореактор для культивирования клеток млекопитающих | |
AR084377A1 (es) | Metodos y composiciones relacionados con enzimas de alcohol graso biosintetico | |
MY151062A (en) | Pseudoinfectious flavivirus and uses thereof | |
IL189193A (en) | Transplastic plants expressing a space-oriented protein | |
EA201492202A1 (ru) | Способ экспрессии гетерологичных белков с использованием рекомбинантного вирусного вектора с минус-нитью рнк | |
AR059650A1 (es) | Plantas que presentan aumento en el rendimiento y metodo para lograrlo | |
AR073602A1 (es) | Metodo para producir un aditivo para la degradacion enzimatica de micotoxinas y aditivo y uso del mismo | |
EA201390592A1 (ru) | Аллели 1-d-дезоксиксилулозо-5-фосфат синтазы, ответственные за усиленный биосинтез терпенов | |
MX2021009554A (es) | Produccion de virus en cultivos celulares. | |
AR082510A1 (es) | Metodo para aumentar la resistencia a infecciones fungicas en plantas transgenicas mediante el gen hcp-2 | |
AR053279A1 (es) | Regulacion post-transcripcional de la expresion genica | |
ES2641014T3 (es) | Gen Dro1 que controla características de enraizamiento profundo de planta y utilización del mismo | |
AR103794A1 (es) | Producción de alquenos | |
AR087980A1 (es) | Actividad de dnasa endogena para reducir el contenido de adn | |
AR095472A1 (es) | Promotores constitutivos de soja | |
AR069885A1 (es) | Metodos para producir el virus de estomatitis vesicular (vsv) atenuado en un cultivo celular y para mejorar el empaque del vsv de propagacion defectuosa, composicion inmunogenica, celula aislada y secuencia de control transcripcional | |
AR100382A1 (es) | Método para producir nailon | |
GB2458419A (en) | Vector for expressing NC protein of HIV and method for producing NC protein using the same | |
AR090340A1 (es) | Operaciones de cosecha mejoradas para proteinas recombinadas |